Icon

SPINRAZA (nda209531)- (EQ 12MG BASE/5ML (EQ 2.4MG BASE/ML))

NUSINERSEN SODIUM BIOGEN IDEC
EQ 12MG BASE/5ML (EQ 2.4MG BASE/ML)
No No
2036-Mar-04 2021-Dec-23
2023-Dec-23 None
None No
SPINRAZA is a survival motor neuron-2 (SMN2)-directed antisense oligonucleotide indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.
0 0 0
Total Other Developers 3
Drugs with Suitability No
EQ 12MG BASE/5ML (EQ 2.4MG BASE/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.